Associations of Matrix Metalloproteinase-8 Genotypes to Renal Cell Carcinoma in Taiwan
Anticancer Research · 2024
DOI: 10.21873/anticanres.16995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Cheng-Hsi Liao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Department of Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Genetic Predisposition to Disease, Genotype, Kidney Neoplasms.
Abstract (Originalsprache)
BACKGROUND/AIM: Renal cell carcinoma (RCC) presents a formidable clinical challenge due to its aggressive behavior and limited therapeutic options. Matrix metalloproteinase-8 (MMP-8) has recently emerged as a potential biomarker and therapeutic target for various cancers. However, the genetic involvement of MMP-8 in RCC has remained largely obscure. This study aimed to elucidate the role of MMP-8 genotypes in RCC susceptibility. MATERIALS AND METHODS: The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was employed to scrutinize the genotypes of MMP-8 C-799T (rs11225395), Val436Ala (rs34009635), and Lys460Thr (rs35866072) among 118 RCC patients and 590 controls. Furthermore, potential associations between MMP-8 genotypes and age, sex, smoking, alcohol consumption, hypertension, diabetes, and family history status in relation to RCC risk were assessed. RESULTS: No significant disparities in the distribution of MMP-8 rs11225395, rs34009635, and rs35866072 genotypes were observed between the RCC case and control cohorts (p>0.05). Individuals with CT and TT genotypes at MMP-8 rs11225395 exhibited 0.86- and 0.80-fold RCC risks, respectively (OR=0.57-1.31 and 0.42-1.55, p=0.5585 and 0.6228, respectively). Intriguingly, hypertensive individuals carrying the MMP-8 rs11225395 CT or TT genotype demonstrated an elevated risk for RCC compared to those with wild-type CC genotype (p=0.0440). No interactions of MMP-8 genotypes with age, sex, smoking, alcohol consumption, or diabetes status were evident (all p>0.05). No significant association was discerned for MMP-8 rs34009635 or rs35866072 genotypes. CONCLUSION: MMP-8 genotypes appear to have a modest influence on individual susceptibility to RCC. Hypertensive patients with the CT or TT MMP-8 rs11225395 genotype may have an elevated risk of RCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Urology, Department of Surgery, Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.
- National Defense Medical Center, Taipei, Taiwan, R.O.C.
- Cell Therapy Center, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan, R.O.C.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
- Department of Nephrology, Chang-Hua Hospital, Ministry of Health and Welfare, Changhua, Taiwan, R.O.C.
- Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Zitieren
APA
Liao, C. H., Chien, W. C., Chang, S. Y., Lin, Y. H., Wang, Y. C., Huang, W. C., Mong, M. C., Yang, Y. C., Wu, W. T., Chen, J. C., Chang, C. H., Tsai, C. W., Bau, D. T., & Chang, W. S. (2024). Associations of Matrix Metalloproteinase-8 Genotypes to Renal Cell Carcinoma in Taiwan. Anticancer Research. https://doi.org/10.21873/anticanres.16995
Vancouver
Liao CH, Chien WC, Chang SY, Lin YH, Wang YC, Huang WC, et al. Associations of Matrix Metalloproteinase-8 Genotypes to Renal Cell Carcinoma in Taiwan. Anticancer Research. 2024. doi:10.21873/anticanres.16995
BibTeX
@article{Liao2024,
author = {Liao, Cheng-Hsi and Chien, Wei-Ching and Chang, Shu-Yu and Lin, Yu-Hsin and Wang, Yun-Chi and Huang, Wen-Chin and Mong, Mei-Chin and Yang, Ya-Chen and Wu, Wen-Tzu and Chen, Jaw-Chyun and Chang, Chao-Hsiang and Tsai, Chia-Wen and Bau, DA-Tian and Chang, Wen-Shin},
title = {Associations of Matrix Metalloproteinase-8 Genotypes to Renal Cell Carcinoma in Taiwan},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16995}
}
EUVIMED